Operating Lease, Right-of-Use Asset of Dare Bioscience, Inc. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Dare Bioscience, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
Dare Bioscience, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $824,693, a 38% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Dare Bioscience, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$824,693	-$503,140	-38%	30 Sep 2025	10-Q	13 Nov 2025	2025	Q3
Q2 2025	$955,651	-$490,172	-34%	30 Jun 2025	10-Q	14 Aug 2025	2025	Q2
Q1 2025	$1,083,036	-$477,670	-31%	31 Mar 2025	10-Q	13 May 2025	2025	Q1
Q4 2024	$1,206,942	-$112,688	-8.5%	31 Dec 2024	10-Q	13 Nov 2025	2025	Q3
Q3 2024	$1,327,833	+$1,145,833	+630%	30 Sep 2024	10-Q	14 Nov 2024	2024	Q3
Q2 2024	$1,445,823	+$1,169,823	+424%	30 Jun 2024	10-Q	12 Aug 2024	2024	Q2
Q1 2024	$1,560,706	+$1,192,706	+324%	31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$1,319,630	+$861,705	+188%	31 Dec 2023	10-K	31 Mar 2025	2024	FY
Q3 2023	$182,000	-$364,000	-67%	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$276,000			30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$368,000			31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$457,925			31 Dec 2022	10-K	28 Mar 2024	2023	FY
Q3 2022	$546,000			30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q3 2019	$173,274			30 Sep 2019	10-Q	12 Nov 2019	2019	Q3
Q2 2019	$193,399			30 Jun 2019	10-Q	14 Aug 2019	2019	Q2
Q1 2019	$212,909			31 Mar 2019	10-Q	14 May 2019	2019	Q1
Q4 2018	$232,000			01 Jan 2019	10-Q	12 Nov 2019	2019	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.